These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23054049)

  • 1. Anticholinergic drugs or botulinum toxin for urge incontinence?
    BMJ; 2012 Oct; 345():e6732. PubMed ID: 23054049
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial.
    Visco AG; Brubaker L; Richter HE; Nygaard I; Paraiso MF; Menefee SA; Schaffer J; Wei J; Chai T; Janz N; Spino C; Meikle S;
    Contemp Clin Trials; 2012 Jan; 33(1):184-96. PubMed ID: 22008247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OnabotulinumtoxinA Injections for Urge Incontinence.
    Hubb AJ; Stachowicz AM; Wood SC
    Am Fam Physician; 2018 Feb; 97(3):Online. PubMed ID: 29431973
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In overactive bladder, above all urgency is stressful. The patients know the site of each toilet].
    MMW Fortschr Med; 2004 May; 146(22):51. PubMed ID: 15373116
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of overactive urinary bladder with imperative urinary incontinence in women].
    Neĭmark AI; Riapolova MV; Mel'nik MA
    Urologiia; 2010; (2):36-8. PubMed ID: 20967993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on: Anticholinergic therapy vs onabotulinumtoxinA for urgency urinary incontinence.
    Kobashi KC; Patel B
    Urology; 2013 Jul; 82(1):14-5. PubMed ID: 23642706
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses.
    Grise P; Ruffion A; Denys P; Egon G; Chartier Kastler E
    Eur Urol; 2010 Nov; 58(5):759-66. PubMed ID: 20674149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Anticholinergics Versus Botox for Urgency Urinary Incontinence: Results From the Anticholinergic Versus Botox Comparison Randomized Trial.
    Visco AG; Zyczynski H; Brubaker L; Nygaard I; Xu X; Lukacz ES; Paraiso MF; Greer J; Rahn DD; Meikle SF; Honeycutt AA
    Female Pelvic Med Reconstr Surg; 2016; 22(5):311-6. PubMed ID: 27564385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Overactive bladder. When it's pressing, immediate help is indicated].
    Widhalm S
    MMW Fortschr Med; 2008 May; 150(20):44-5. PubMed ID: 18605642
    [No Abstract]   [Full Text] [Related]  

  • 11. Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder.
    Kantartzis K; Shepherd J
    Curr Opin Obstet Gynecol; 2012 Oct; 24(5):331-6. PubMed ID: 22922403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solifenacin significantly improves all symptoms of overactive bladder syndrome.
    Chapple CR; Cardozo L; Steers WD; Govier FE
    Int J Clin Pract; 2006 Aug; 60(8):959-66. PubMed ID: 16893438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of imidafenacin in female patients with urge and mixed urinary incontinence].
    Shimada M; Inoue K; Okumura T; Aoki S; Ogawa Y; Matsubara E; Maeda T; Ogawa Y; Sasaki H
    Hinyokika Kiyo; 2011 Jan; 57(1):1-6. PubMed ID: 21304252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary urgency].
    MMW Fortschr Med; 2008 Jul; 150(28-31):58-9. PubMed ID: 19009709
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
    Rickey LM; Kenton K
    Clin Obstet Gynecol; 2008 Mar; 51(1):176-86. PubMed ID: 18303512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry.
    Nilsson FO; Linnér L; Samuelsson E; Milsom I
    BJU Int; 2012 Jul; 110(2):240-6. PubMed ID: 22093912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Declaration of the principles for the administration of botulinum toxin].
    Plast Reconstr Surg; 2004 Oct; 114(5 Suppl):5S-6S. PubMed ID: 15722912
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticholinergic drugs versus non-drug treatment of overactive bladder syndrome in adults. A survey of a Cochrane review].
    Nordling J
    Ugeskr Laeger; 2007 Dec; 169(50):4345-7. PubMed ID: 18211791
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Cost-Effectiveness Analysis of Anticholinergics versus Botox for Urgency Urinary Incontinence: Results from the Anticholinergic versus Botox Comparison Randomized Trial.
    Wein AJ
    J Urol; 2017 Sep; 198(3):487-492. PubMed ID: 28817919
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with solifenacin reduces urinary urgency and improves quality of life. Results of the non-interventional CAP-study].
    Kalchthaler M; Mühlich S; Rothe P
    MMW Fortschr Med; 2011 Jan; 152 Suppl 4():119-24. PubMed ID: 21598462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.